Skip to main content
Equibles
FCHS logo

FCHS · First Choice Healthcare Solutions, Inc.

Track FCHS — free

Use FCHS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.01 At close · Aug 31
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“If the Company is unable to secure additional capital, it may have to curtail its business development initiatives and take additional measures to reduce costs in order to conserve its cash, thus raising substantial doubt about its ability to continue as a going concern more than one year from the date of issuance of the 2025 financial statements included in this filing.”
View the 10-Q filed Aug 13, 2026
Market Cap
$263,666
Shares
32.96M

FCHS metrics

46 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.01
Market cap
$263,666

Price action

19 metrics
Price change (1W)
+0.0%
Price change (30D)
-30.8%
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
+176.7%
Price change (1Y)
-30.8%
Trailing year
Price change (5Y)
-94.1%
52-week high
$0.02
52-week low
$0.00
Change from 52-week high
-65.4%
Change from 52-week low
+176.7%
Annualized volatility
—
Beta
—
RSI (14D)
45.7
Price vs SMA 50
-9.8%
Price vs SMA 200
-3.2%
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
32.96M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
8.7×
reciprocal yield 11.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.3×
reciprocal yield 396.9%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-5,071.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
-93.3%
Trailing 12 months
Net margin
-448.7%
Gross profit (TTM)
$7,350
Operating profit (TTM)
−$2.78M
Net income (TTM)
−$13.37M
Trailing 12 months
Diluted EPS (TTM)
$-0.40
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.62

Growth

11 metrics
Revenue growth YoY
+1.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.05M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
-6.0%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-2,319.5%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
−$2.77M
Free cash flow (TTM)
—
Quick ratio
0.0
Interest coverage
-0.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$6,842
Total assets
$576,493
Total debt
$2.69M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$485,788
Capital expenditures (TTM)
$82,918
R&D (TTM)
—
SG&A (TTM)
$2.04M
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
28 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1416876 Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)